152 related articles for article (PubMed ID: 12632456)
1. Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al.
Matejicka C; Morgan GJ; Schlegelmilch JG
Arthritis Rheum; 2003 Mar; 48(3):864-6. PubMed ID: 12632456
[No Abstract] [Full Text] [Related]
2. Treatment of multicentric reticulohistiocytosis with etanercept.
Kovach BT; Calamia KT; Walsh JS; Ginsburg WW
Arch Dermatol; 2004 Aug; 140(8):919-21. PubMed ID: 15313806
[No Abstract] [Full Text] [Related]
3. Healing of erosive disease in multicentric reticulohistiocytosis.
Broadwell AW; Calamia KT; Kransdorf MJ; Ginsburg WW
J Rheumatol; 2010 Jun; 37(6):1366-7. PubMed ID: 20516048
[No Abstract] [Full Text] [Related]
4. Etanercept and the treatment of multicentric reticulohistiocytosis.
Lovelace K; Loyd A; Adelson D; Crowson N; Taylor JR; Cornelison R
Arch Dermatol; 2005 Sep; 141(9):1167-8. PubMed ID: 16172321
[No Abstract] [Full Text] [Related]
5. Etanercept therapy of psoriatic arthritis in a patient with liver cirrhosis.
Lehnen M; Franckson T; Korber A; Grabbe S; Dissemond J
Acta Derm Venereol; 2005; 85(4):351-2. PubMed ID: 16191861
[No Abstract] [Full Text] [Related]
6. Etanercept in breast milk.
Ostensen M; Eigenmann GO
J Rheumatol; 2004 May; 31(5):1017-8. PubMed ID: 15124283
[No Abstract] [Full Text] [Related]
7. Failure of etanercept therapy in disseminated granuloma annulare.
Kreuter A; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1236-7; author reply 1237. PubMed ID: 16983020
[No Abstract] [Full Text] [Related]
8. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR
Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
[TBL] [Abstract][Full Text] [Related]
9. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
Papp KA; Tyring S; Lahfa M; Prinz J; Griffiths CE; Nakanishi AM; Zitnik R; van de Kerkhof PC; Melvin L;
Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
[TBL] [Abstract][Full Text] [Related]
10. Etanercept AL amyloidosis.
Drewe E; Powell RJ
Lancet; 2001 Sep; 358(9283):761. PubMed ID: 11556345
[No Abstract] [Full Text] [Related]
11. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.
Zeichner JA; Stern DW; Lebwohl M
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S120-1. PubMed ID: 16488322
[No Abstract] [Full Text] [Related]
12. Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.
Kikuchi H; Yamamoto T; Asako K; Takayama M; Shirasaki R; Ono Y
Mod Rheumatol; 2012 Apr; 22(2):308-11. PubMed ID: 21773824
[TBL] [Abstract][Full Text] [Related]
13. Multicentric reticulohistiocytosis with positive anticyclic citrullinated antibodies.
Chauhan A; Mikulik Z; Hackshaw KV
J Natl Med Assoc; 2007 Jun; 99(6):678-80. PubMed ID: 17595939
[TBL] [Abstract][Full Text] [Related]
14. Generalized pustular psoriasis of Zambusch: case report of successful disease control with cyclosporine and etanercept.
Vine K; Votava HJ; Smith BL
Cutis; 2012 Sep; 90(3):132-6. PubMed ID: 23094312
[TBL] [Abstract][Full Text] [Related]
15. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Kremer JM; Weinblatt ME; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Jackson CG; Atkins KM; Feng A; Burge DJ
Arthritis Rheum; 2003 Jun; 48(6):1493-9. PubMed ID: 12794815
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration.
Hernandez-Illas M; Tozman E; Fulcher SF; Jundt JW; Davis J; Pflugfelder SC
Eye Contact Lens; 2004 Jan; 30(1):2-5. PubMed ID: 14722460
[TBL] [Abstract][Full Text] [Related]
17. [Etanercept: enbrel].
Sparsa A
Ann Dermatol Venereol; 2007 Dec; 134(12):972-7. PubMed ID: 18166920
[No Abstract] [Full Text] [Related]
18. Immunologic targets in psoriasis.
Kupper TS
N Engl J Med; 2003 Nov; 349(21):1987-90. PubMed ID: 14627782
[No Abstract] [Full Text] [Related]
19. Successful treatment of Langerhans'-cell histiocytosis with etanercept.
Henter JI; Karlén J; Calming U; Bernstrand C; Andersson U; Fadeel B
N Engl J Med; 2001 Nov; 345(21):1577-8. PubMed ID: 11794238
[No Abstract] [Full Text] [Related]
20. Etanercept for the treatment of psoriasis and psoriatic arthritis.
Gottlieb AB
Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
